Our lab has been working with a number of collaborators on a study of lateral flow assays for the detection of SARS-CoV-2 antibodies. We’ve designed and implemented an interactive app to complement the study. Interested parties getting an antibody test are advised to speak with their healthcare provider about interpreting their results with that app, which uses local COVID19 prevelance data from usafacts.org (also used by the CDC) and measurments from the study to estimate the probability they do or do not have SARS-CoV-2 antibodies given their result.